CMS certification 460009
University of Utah Hospital and Clinics
50 North Medical Drive, Salt Lake City, UT 84132
University of Utah Hospital and Clinics has a CMS overall rating of 5 out of 5 stars. 83% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. Emergency patients spend a median of 3 h 54 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,497 completed surveys, 27% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | UT | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 380 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 54 min | 2 h 13 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 30 visits sampled | 6 h 12 min | 3 h 25 min | 4 h 17 min |
| Left before being seen Lower is better · 73,973 patients | 5% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 126 patients | 52% | 68% | 65% |
How University of Utah Hospital and Clinics compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| University of Utah Hospital and ClinicsThis hospital | 5/5 | 83% | 3 h 54 min | 7 better 2 worse |
| St Mark's HospitalSame city | 4/5 | 72% | 1 h 49 min | 5 better |
| Lds HospitalSame city | 5/5 | 75% | 2 h 56 min | 5 better |
| VA Salt Lake City Healthcare - George E. Wahlen VA Medical CenterSame city | 4/5 | 80% | — | 2 better |
| Holy Cross Hospital - Salt LakeSame city | 3/5 | 66% | 2 h 26 min | 1 better |
| Intermountain Medical CenterSame county · Murray | 5/5 | 78% | 3 h 38 min | 9 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Salt Lake City.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,004 cases | Too few cases | 2.7% | 3.9% |
| Heart attack 168 cases | Too few cases | 12% | 11.9% |
| Heart failure 423 cases | Too few cases | 9.1% | 11.1% |
| Pneumonia 347 cases | Too few cases | 12.7% | 15.2% |
| Stroke 506 cases | Too few cases | 10.8% | 11.9% |
| COPD 69 cases | Too few cases | 8.3% | 8.6% |
| Heart bypass surgery (CABG) 68 cases | Too few cases | 1.8% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.91 likely 0.6 – 1.22 | 1 |
| After hip or knee replacement 289 cases | Too few cases | 2.8% | 4.1% |
| Deaths after a serious but treatable surgical complication 297 cases | No different | 156.56 per 1,000 likely 123.99 per 1,000 – 189.13 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 10,150 cases | No different | 0.5 per 1,000 likely 0.08 per 1,000 – 0.92 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,361 cases | No different | 0.19 per 1,000 likely 0.02 per 1,000 – 0.37 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 12,089 cases | No different | 0.26 per 1,000 likely 0.08 per 1,000 – 0.43 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 4,443 cases | No different | 2.55 per 1,000 likely 1.5 per 1,000 – 3.59 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 204 cases | No different | 1.58 per 1,000 likely 0 per 1,000 – 3.27 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 212 cases | No different | 6.76 per 1,000 likely 0 per 1,000 – 15.4 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,881 cases | No different | 4.06 per 1,000 likely 2.7 per 1,000 – 5.41 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 198 cases | No different | 5.49 per 1,000 likely 1.4 per 1,000 – 9.58 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,317 cases | No different | 1.88 per 1,000 likely 0.63 per 1,000 – 3.14 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,231 cases | No different | 0.78 per 1,000 likely 0.03 per 1,000 – 1.53 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.55 likely 0.36 – 0.81 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.6 likely 0.4 – 0.87 | 1 |
| Surgical site infections after colon surgery | No different | 0.74 likely 0.44 – 1.16 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.2 likely 0.01 – 1.01 | 1 |
| MRSA bloodstream infections | Better | 0.6 likely 0.33 – 0.99 | 1 |
| C. diff intestinal infections | Better | 0.52 likely 0.42 – 0.64 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 213 cases | Too few cases | 13.5% | 14.4% |
| Readmitted after heart failure 664 cases | Too few cases | 17.5% | 21.3% |
| Readmitted after pneumonia 535 cases | Too few cases | 16.2% | 17.3% |
| Readmitted after COPD 113 cases | Too few cases | 18.2% | 20% |
| Readmitted after heart bypass surgery 72 cases | Too few cases | 10% | 11% |
| Readmitted after hip or knee replacement 310 cases | Too few cases | 5.4% | 5.8% |
| Days back in hospital after a heart attack 180 cases | Too few cases | 0.4 days per 100 | — |
| Days back in hospital after heart failure 478 cases | Too few cases | -34.8 days per 100 | — |
| Days back in hospital after pneumonia 374 cases | Too few cases | -7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,684 cases | No different | 12.6 per 1,000 likely 9.9 per 1,000 – 15.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,119 cases | Better | 8.8 per 100 likely 7.3 per 100 – 10.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,119 cases | No different | 5.8 per 100 likely 4.6 per 100 – 7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 2,156 cases | No different | 1.1 likely 0.9 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
1,315 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 115 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Physical Therapist | 142 |
| Occupational Therapist | 100 |
| Physician Assistant | 60 |
| Anesthesiology | 51 |
| Pharmacist | 51 |
| Nurse Practitioner | 46 |
| Family | 41 |
| Internal Medicine | 41 |
| Acute Care | 35 |
| Hospitalist | 32 |
| Speech-Language Pathologist | 32 |
| Pediatrics | 30 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $25.6M
- 2020 $25.2M
- 2021 $25.2M
- 2022 $25.4M
- 2023 $29.4M
- 2024 $35M
- 2025 $37.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $1.7M | 60 |
| Speaking, teaching and other services | $771,353 | 34 |
| Space rental and facility fees | $538,105 | 92 |
| Consulting fees | $429,856 | 9 |
| Royalties and licensing fees | $128,925 | 5 |
| Education | $93,707 | 20 |
| Medical devices and supplies on long-term loan | $36,710 | 3 |
| Debt forgiveness | $13,746 | 10 |
| Gifts | $9,500 | 3 |
| Charitable contributions | $6,620 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3.3M | 23 |
| Merck Sharp & Dohme LLC | $3.3M | 37 |
| Janssen Research & Development, LLC | $2.3M | 197 |
| Abbvie INC. | $1.9M | 224 |
| Novavax Inc | $1.8M | 5 |
| E.R. Squibb & Sons, L.L.C. | $1.6M | 25 |
| Pfizer INC. | $1.6M | 172 |
| Regeneron Pharmaceuticals, Inc. | $1.4M | 73 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patient… AstraZeneca Pharmaceuticals LP | $1.6M |
| A randomized, phase II study of staggered, chemo-immunotherapy with Durvalumab, Pemetrexed and Carboplatin for metastatic Non-squamous NSCLC with Hos… AstraZeneca Pharmaceuticals LP | $995,472 |
| Novavax Vaccine Efficacy Real World Trial Novavax Inc | $915,892 |
| A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patient… BeOne Medicines Ltd. · NCT06073821 | $889,418 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS … Regeneron Pharmaceuticals, Inc. · NCT04206553 | $783,950 |
| Study of Health Care Workers And First Responders Investigating Effects Of Systemic and Local Reactogenicity of COVID-19 Vaccine Doses in Utah (SHIEL… Novavax Inc | $775,019 |
| Phase 1b Study to Investigate ABBV-CLS-7262 s Safety Tolerability & Pharmacokinetics in Vanishing White Matter Patients ABBVIE INC. · NCT05757141 | $673,349 |
| An Open-Label Phase 2 Study to Evaluate PT2977 For The Treatment of Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma Merck Sharp & Dohme LLC | $559,948 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about University of Utah Hospital and Clinics
Is University of Utah Hospital and Clinics a good hospital?
University of Utah Hospital and Clinics has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend University of Utah Hospital and Clinics?
83% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,497 completed HCAHPS surveys.
How long is the wait in the University of Utah Hospital and Clinics emergency room?
Emergency patients spend a median of 3 h 54 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 5% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does University of Utah Hospital and Clinics receive money from drug and device companies?
Drug and device makers reported $37.1M in payments to University of Utah Hospital and Clinics for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.